Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

269 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Recruiting

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

NCT04421820

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +22 more
Locations
  • University of California, Los Angeles Santa Monica, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Cross Cancer Institue Edmonton, Alberta, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
View all 24 locations
View Trial Details
Recruiting

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

NCT06441747

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
  • Monash Medical Centre Clayton, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

NCT06723236

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +21 more
Locations
  • UCSF - Helen Diller Family Cancer Center San Francisco, California, United States
  • Mass General Brigham Boston, Massachusetts, United States
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details

Related conditions